Cloned (Comment) | Organism |
---|---|
expressed in baculovirus-infected High Five insect cells as N-terminal His-tagged fusion proteins | Homo sapiens |
expressed in baculovirus-infected High Five insect cells as N-terminal His-tagged fusion proteins | Rattus norvegicus |
Inhibitors | Comment | Organism | Structure |
---|---|---|---|
1-[4-(4-[[6-(propan-2-yloxy)pyridin-3-yl]oxy]phenyl)butan-2-yl]urea | - |
Homo sapiens | |
anthracen-9-yl[(3R)-3-(morpholin-4-ylcarbonyl)-1,4'-bipiperidin-1'-yl]methanone | - |
Homo sapiens | |
methyl [4-(4-[[6-(propan-2-yloxy)pyridin-3-yl]oxy]phenyl)butan-2-yl]carbamate | - |
Homo sapiens | |
N-(3-[5-[3-(2-cyclopentylethoxy)phenyl]-1,3-dioxan-2-yl]propyl)acetamide | - |
Homo sapiens | |
N-(3-[5-[3-(2-cyclopropylethoxy)phenyl]-1,3-dioxan-2-yl]propyl)acetamide | - |
Homo sapiens | |
N-(3-[5-[3-(2-phenylethoxy)phenyl]-1,3-dioxan-2-yl]propyl)acetamide | - |
Homo sapiens | |
N-(3-[5-[3-(cyclobutylmethoxy)phenyl]-1,3-dioxan-2-yl]propyl)acetamide | - |
Homo sapiens | |
N-(3-[5-[6-(cyclopentyloxy)naphthalen-1-yl]-1,3-dioxan-2-yl]propyl)acetamide | moderate selective isoform ACC2 inhibitor | Homo sapiens | |
N-(3-[cis-5-[4-(benzyloxy)phenoxy]-1,3-dioxan-2-yl]propyl)acetamide | - |
Homo sapiens | |
N-(3-[trans-5-[4-(benzyloxy)phenoxy]-1,3-dioxan-2-yl]propyl)acetamide | - |
Homo sapiens | |
N-(3-[trans-5-[4-(cyclopentyloxy)phenoxy]-1,3-dioxan-2-yl]propyl)acetamide | - |
Homo sapiens | |
N-[(2R)-4-(4-[[5-(benzyloxy)pyridin-2-yl]oxy]phenyl)butan-2-yl]acetamide | - |
Homo sapiens | |
N-[(2R)-4-(4-[[6-(propan-2-yloxy)pyridin-3-yl]oxy]phenyl)butan-2-yl]acetamide | - |
Homo sapiens | |
N-[(2S)-1-(4-[[6-(propan-2-yloxy)pyridin-3-yl]oxy]phenoxy)propan-2-yl]acetamide | - |
Homo sapiens | |
N-[(2S)-4-(4-[[5-(benzyloxy)pyridin-2-yl]oxy]phenyl)butan-2-yl]acetamide | - |
Homo sapiens | |
N-[(2S)-4-(4-[[5-(propan-2-yloxy)pyridin-2-yl]oxy]phenyl)butan-2-yl]acetamide | - |
Homo sapiens | |
N-[(2S)-4-(4-[[6-(propan-2-yloxy)pyridin-3-yl]oxy]phenyl)butan-2-yl]acetamide | - |
Homo sapiens | |
N-[(2S)-4-(4-[[6-(propan-2-yloxy)pyridin-3-yl]oxy]phenyl)butan-2-yl]cyclopropanecarboxamide | - |
Homo sapiens | |
N-[(2S)-4-[2-[4-(propan-2-yloxy)phenoxy]-1,3-thiazol-5-yl]but-3-yn-2-yl]acetamide | - |
Homo sapiens | |
N-[(R)-3-[4-(6-isopropoxy-pyridin-3-yloxy)-phenyl]-1-methyl-propyl]-acetamide | submicromolar dualACC1/2 inhibitor | Homo sapiens | |
N-[(R)-3-[4-(6-isopropoxy-pyridin-3-yloxy)-phenyl]-1-methyl-propyl]-acetamide | submicromolar dualACC1/2 inhibitor | Rattus norvegicus | |
N-[(S)-3-[4-(6-isopropoxy-pyridin-3-yloxy)-phenyl]-1-methyl-propyl]-acetamide | submicromolar dualACC1/2 inhibitor | Homo sapiens | |
N-[(S)-3-[4-(6-isopropoxy-pyridin-3-yloxy)-phenyl]-1-methyl-propyl]-acetamide | submicromolar dualACC1/2 inhibitor | Rattus norvegicus | |
N-[3-(4-[[5-(cyclopentyloxy)pyridin-2-yl]oxy]phenyl)propyl]acetamide | - |
Homo sapiens | |
N-[3-(trans-5-[[5-(benzyloxy)pyridin-2-yl]oxy]-1,3-dioxan-2-yl)propyl]acetamide | - |
Homo sapiens | |
N-[4-(4-[[2-(propan-2-yloxy)pyrimidin-5-yl]oxy]phenyl)butan-2-yl]acetamide | - |
Homo sapiens | |
N-[4-(4-[[5-(benzyloxy)pyridin-2-yl]oxy]phenyl)butan-2-yl]acetamide | - |
Homo sapiens | |
N-[4-(4-[[5-(cyclopentyloxy)pyridin-2-yl]oxy]phenyl)butan-2-yl]acetamide | - |
Homo sapiens | |
N-[4-(4-[[5-(propan-2-yloxy)pyrazin-2-yl]oxy]phenyl)butan-2-yl]acetamide | - |
Homo sapiens | |
N-[4-(4-[[5-(propan-2-yloxy)pyridin-2-yl]oxy]phenyl)butan-2-yl]acetamide | - |
Homo sapiens | |
N-[4-(4-[[6-(benzyloxy)pyridin-3-yl]oxy]phenyl)butan-2-yl]acetamide | - |
Homo sapiens | |
N-[4-(4-[[6-(propan-2-yloxy)pyridazin-3-yl]oxy]phenyl)butan-2-yl]acetamide | - |
Homo sapiens | |
N-[4-(4-[[6-(propan-2-yloxy)pyridin-3-yl]oxy]phenyl)butan-2-yl]cyclopropanecarboxamide | - |
Homo sapiens | |
N-[4-(4-[[6-(propan-2-yloxy)pyridin-3-yl]oxy]phenyl)butan-2-yl]formamide | - |
Homo sapiens |
Organism | UniProt | Comment | Textmining |
---|---|---|---|
Homo sapiens | - |
- |
- |
Rattus norvegicus | - |
- |
- |
Purification (Comment) | Organism |
---|---|
Ni-affinity column chromatography and gel filtration | Homo sapiens |
Ni-affinity column chromatography and gel filtration | Rattus norvegicus |
Source Tissue | Comment | Organism | Textmining |
---|---|---|---|
liver | - |
Homo sapiens | - |
liver | - |
Rattus norvegicus | - |
Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|
ATP + acetyl-CoA + HCO3- | - |
Homo sapiens | ADP + malonyl-CoA + phosphate | - |
? | |
ATP + acetyl-CoA + HCO3- | - |
Rattus norvegicus | ADP + malonyl-CoA + phosphate | - |
? |
Synonyms | Comment | Organism |
---|---|---|
ACC1 | isoform | Homo sapiens |
ACC1 | isoform | Rattus norvegicus |
ACC2 | isoform | Homo sapiens |
ACC2 | isoform | Rattus norvegicus |
Acetyl CoA carboxylase | - |
Homo sapiens |
Acetyl CoA carboxylase | - |
Rattus norvegicus |
IC50 Value | IC50 Value Maximum | Comment | Organism | Inhibitor | Structure |
---|---|---|---|---|---|
0.000015 | - |
isoform ACC2, in 50 mM Tris-acetate, at 37°C, pH not specified in the publication | Homo sapiens | N-[(2S)-4-(4-[[6-(propan-2-yloxy)pyridin-3-yl]oxy]phenyl)butan-2-yl]acetamide | |
0.00003 | - |
isoform ACC2, in 50 mM Tris-acetate, at 37°C, pH not specified in the publication | Homo sapiens | N-[(2S)-4-(4-[[6-(propan-2-yloxy)pyridin-3-yl]oxy]phenyl)butan-2-yl]acetamide | |
0.00006 | - |
isoform ACC2, in 50 mM Tris-acetate, at 37°C, pH not specified in the publication | Homo sapiens | N-[(2S)-1-(4-[[6-(propan-2-yloxy)pyridin-3-yl]oxy]phenoxy)propan-2-yl]acetamide | |
0.00006 | - |
isoform ACC2, in 50 mM Tris-acetate, at 37°C, pH not specified in the publication | Homo sapiens | N-[(2S)-4-[2-[4-(propan-2-yloxy)phenoxy]-1,3-thiazol-5-yl]but-3-yn-2-yl]acetamide | |
0.00007 | - |
isoform ACC2, in 50 mM Tris-acetate, at 37°C, pH not specified in the publication | Homo sapiens | anthracen-9-yl[(3R)-3-(morpholin-4-ylcarbonyl)-1,4'-bipiperidin-1'-yl]methanone | |
0.00007 | - |
isoform ACC2, in 50 mM Tris-acetate, at 37°C, pH not specified in the publication | Homo sapiens | N-[3-(trans-5-[[5-(benzyloxy)pyridin-2-yl]oxy]-1,3-dioxan-2-yl)propyl]acetamide | |
0.00008 | - |
isoform ACC2, in 50 mM Tris-acetate, at 37°C, pH not specified in the publication | Homo sapiens | N-[4-(4-[[6-(benzyloxy)pyridin-3-yl]oxy]phenyl)butan-2-yl]acetamide | |
0.00008 | - |
isoform ACC2, in 50 mM Tris-acetate, at 37°C, pH not specified in the publication | Homo sapiens | N-[(2S)-4-(4-[[6-(propan-2-yloxy)pyridin-3-yl]oxy]phenyl)butan-2-yl]cyclopropanecarboxamide | |
0.0001 | - |
isoform ACC2, in 50 mM Tris-acetate, at 37°C, pH not specified in the publication | Homo sapiens | N-[(2S)-4-(4-[[5-(benzyloxy)pyridin-2-yl]oxy]phenyl)butan-2-yl]acetamide | |
0.00014 | - |
isoform ACC1, in 50 mM Tris-acetate, at 37°C, pH not specified in the publication | Homo sapiens | N-[(2S)-4-(4-[[6-(propan-2-yloxy)pyridin-3-yl]oxy]phenyl)butan-2-yl]acetamide | |
0.00014 | - |
isoform ACC2, in 50 mM Tris-acetate, at 37°C, pH not specified in the publication | Homo sapiens | N-[4-(4-[[5-(cyclopentyloxy)pyridin-2-yl]oxy]phenyl)butan-2-yl]acetamide | |
0.00015 | - |
isoform ACC2, in 50 mM Tris-acetate, at 37°C, pH not specified in the publication | Homo sapiens | 1-[4-(4-[[6-(propan-2-yloxy)pyridin-3-yl]oxy]phenyl)butan-2-yl]urea | |
0.00017 | - |
isoform ACC1, in 50 mM Tris-acetate, at 37°C, pH not specified in the publication | Homo sapiens | N-[(2S)-4-(4-[[6-(propan-2-yloxy)pyridin-3-yl]oxy]phenyl)butan-2-yl]acetamide | |
0.00019 | - |
isoform ACC1, in 50 mM Tris-acetate, at 37°C, pH not specified in the publication | Homo sapiens | N-[(2S)-4-(4-[[6-(propan-2-yloxy)pyridin-3-yl]oxy]phenyl)butan-2-yl]acetamide | |
0.00019 | - |
isoform ACC2, in 50 mM Tris-acetate, at 37°C, pH not specified in the publication | Homo sapiens | N-(3-[trans-5-[4-(cyclopentyloxy)phenoxy]-1,3-dioxan-2-yl]propyl)acetamide | |
0.00019 | - |
isoform ACC2, in 50 mM Tris-acetate, at 37°C, pH not specified in the publication | Homo sapiens | N-[4-(4-[[6-(propan-2-yloxy)pyridin-3-yl]oxy]phenyl)butan-2-yl]cyclopropanecarboxamide | |
0.0002 | - |
isoform ACC2, in 50 mM Tris-acetate, at 37°C, pH not specified in the publication | Homo sapiens | N-[(2S)-4-(4-[[6-(propan-2-yloxy)pyridin-3-yl]oxy]phenyl)butan-2-yl]acetamide | |
0.0002 | - |
isoform ACC2, in 50 mM Tris-acetate, at 37°C, pH not specified in the publication | Homo sapiens | N-[4-(4-[[5-(propan-2-yloxy)pyridin-2-yl]oxy]phenyl)butan-2-yl]acetamide | |
0.0002 | - |
isoform ACC2, in 50 mM Tris-acetate, at 37°C, pH not specified in the publication | Homo sapiens | N-[(2S)-4-(4-[[5-(propan-2-yloxy)pyridin-2-yl]oxy]phenyl)butan-2-yl]acetamide | |
0.00021 | - |
isoform ACC2, in 50 mM Tris-acetate, at 37°C, pH not specified in the publication | Homo sapiens | N-[4-(4-[[5-(benzyloxy)pyridin-2-yl]oxy]phenyl)butan-2-yl]acetamide | |
0.00025 | - |
isoform ACC2, in 50 mM Tris-acetate, at 37°C, pH not specified in the publication | Homo sapiens | methyl [4-(4-[[6-(propan-2-yloxy)pyridin-3-yl]oxy]phenyl)butan-2-yl]carbamate | |
0.00027 | - |
isoform ACC2, in 50 mM Tris-acetate, at 37°C, pH not specified in the publication | Homo sapiens | N-(3-[5-[3-(2-cyclopentylethoxy)phenyl]-1,3-dioxan-2-yl]propyl)acetamide | |
0.00028 | - |
isoform ACC2, in 50 mM Tris-acetate, at 37°C, pH not specified in the publication | Homo sapiens | anthracen-9-yl[(3R)-3-(morpholin-4-ylcarbonyl)-1,4'-bipiperidin-1'-yl]methanone | |
0.00036 | - |
isoform ACC1, in 50 mM Tris-acetate, at 37°C, pH not specified in the publication | Homo sapiens | N-[(2S)-4-(4-[[6-(propan-2-yloxy)pyridin-3-yl]oxy]phenyl)butan-2-yl]cyclopropanecarboxamide | |
0.00038 | - |
isoform ACC2, in 50 mM Tris-acetate, at 37°C, pH not specified in the publication | Homo sapiens | N-[(2S)-4-[2-[4-(propan-2-yloxy)phenoxy]-1,3-thiazol-5-yl]but-3-yn-2-yl]acetamide | |
0.0004 | - |
isoform ACC2, in 50 mM Tris-acetate, at 37°C, pH not specified in the publication | Homo sapiens | N-[(2S)-4-(4-[[6-(propan-2-yloxy)pyridin-3-yl]oxy]phenyl)butan-2-yl]acetamide | |
0.0004 | - |
isoform ACC2, in 50 mM Tris-acetate, at 37°C, pH not specified in the publication | Homo sapiens | N-(3-[trans-5-[4-(benzyloxy)phenoxy]-1,3-dioxan-2-yl]propyl)acetamide | |
0.00059 | - |
isoform ACC1, in 50 mM Tris-acetate, at 37°C, pH not specified in the publication | Homo sapiens | anthracen-9-yl[(3R)-3-(morpholin-4-ylcarbonyl)-1,4'-bipiperidin-1'-yl]methanone | |
0.0006 | - |
isoform ACC2, in 50 mM Tris-acetate, at 37°C, pH not specified in the publication | Homo sapiens | N-[(2S)-1-(4-[[6-(propan-2-yloxy)pyridin-3-yl]oxy]phenoxy)propan-2-yl]acetamide | |
0.00062 | - |
isoform ACC1, in 50 mM Tris-acetate, at 37°C, pH not specified in the publication | Homo sapiens | N-[4-(4-[[6-(propan-2-yloxy)pyridin-3-yl]oxy]phenyl)butan-2-yl]cyclopropanecarboxamide | |
0.00063 | - |
isoform ACC2, in 50 mM Tris-acetate, at 37°C, pH not specified in the publication | Homo sapiens | N-(3-[5-[6-(cyclopentyloxy)naphthalen-1-yl]-1,3-dioxan-2-yl]propyl)acetamide | |
0.00067 | - |
isoform ACC2, in 50 mM Tris-acetate, at 37°C, pH not specified in the publication | Homo sapiens | N-[4-(4-[[6-(propan-2-yloxy)pyridin-3-yl]oxy]phenyl)butan-2-yl]formamide | |
0.0007 | - |
isoform ACC1, in 50 mM Tris-acetate, at 37°C, pH not specified in the publication | Homo sapiens | N-[4-(4-[[6-(benzyloxy)pyridin-3-yl]oxy]phenyl)butan-2-yl]acetamide | |
0.0007 | - |
isoform ACC2, in 50 mM Tris-acetate, at 37°C, pH not specified in the publication | Homo sapiens | N-[4-(4-[[2-(propan-2-yloxy)pyrimidin-5-yl]oxy]phenyl)butan-2-yl]acetamide | |
0.0007 | - |
isoform ACC2, in 50 mM Tris-acetate, at 37°C, pH not specified in the publication | Homo sapiens | N-[(2S)-4-(4-[[6-(propan-2-yloxy)pyridin-3-yl]oxy]phenyl)butan-2-yl]cyclopropanecarboxamide | |
0.0007 | - |
isoform ACC2, in 50 mM Tris-acetate, at 37°C, pH not specified in the publication | Homo sapiens | N-(3-[5-[3-(cyclobutylmethoxy)phenyl]-1,3-dioxan-2-yl]propyl)acetamide | |
0.00075 | - |
isoform ACC1, in 50 mM Tris-acetate, at 37°C, pH not specified in the publication | Homo sapiens | N-[4-(4-[[5-(benzyloxy)pyridin-2-yl]oxy]phenyl)butan-2-yl]acetamide | |
0.0008 | - |
isoform ACC1, in 50 mM Tris-acetate, at 37°C, pH not specified in the publication | Homo sapiens | N-[(2S)-4-(4-[[6-(propan-2-yloxy)pyridin-3-yl]oxy]phenyl)butan-2-yl]cyclopropanecarboxamide | |
0.00091 | - |
isoform ACC1, in 50 mM Tris-acetate, at 37°C, pH not specified in the publication | Homo sapiens | anthracen-9-yl[(3R)-3-(morpholin-4-ylcarbonyl)-1,4'-bipiperidin-1'-yl]methanone | |
0.00092 | - |
isoform ACC1, in 50 mM Tris-acetate, at 37°C, pH not specified in the publication | Homo sapiens | N-[(2S)-4-(4-[[5-(benzyloxy)pyridin-2-yl]oxy]phenyl)butan-2-yl]acetamide | |
0.0011 | - |
isoform ACC1, in 50 mM Tris-acetate, at 37°C, pH not specified in the publication | Homo sapiens | N-[4-(4-[[5-(cyclopentyloxy)pyridin-2-yl]oxy]phenyl)butan-2-yl]acetamide | |
0.0011 | - |
isoform ACC1, in 50 mM Tris-acetate, at 37°C, pH not specified in the publication | Homo sapiens | N-[4-(4-[[6-(benzyloxy)pyridin-3-yl]oxy]phenyl)butan-2-yl]acetamide | |
0.00114 | - |
isoform ACC1, in 50 mM Tris-acetate, at 37°C, pH not specified in the publication | Homo sapiens | N-[(2S)-4-(4-[[6-(propan-2-yloxy)pyridin-3-yl]oxy]phenyl)butan-2-yl]acetamide | |
0.0012 | - |
isoform ACC1, in 50 mM Tris-acetate, at 37°C, pH not specified in the publication | Homo sapiens | N-[(2S)-4-(4-[[5-(benzyloxy)pyridin-2-yl]oxy]phenyl)butan-2-yl]acetamide | |
0.0012 | - |
isoform ACC1, in 50 mM Tris-acetate, at 37°C, pH not specified in the publication | Homo sapiens | methyl [4-(4-[[6-(propan-2-yloxy)pyridin-3-yl]oxy]phenyl)butan-2-yl]carbamate | |
0.0012 | - |
isoform ACC1, in 50 mM Tris-acetate, at 37°C, pH not specified in the publication | Homo sapiens | 1-[4-(4-[[6-(propan-2-yloxy)pyridin-3-yl]oxy]phenyl)butan-2-yl]urea | |
0.0012 | - |
isoform ACC2, in 50 mM Tris-acetate, at 37°C, pH not specified in the publication | Homo sapiens | N-[4-(4-[[5-(propan-2-yloxy)pyrazin-2-yl]oxy]phenyl)butan-2-yl]acetamide | |
0.00128 | - |
isoform ACC2, in 50 mM Tris-acetate, at 37°C, pH not specified in the publication | Homo sapiens | N-[3-(4-[[5-(cyclopentyloxy)pyridin-2-yl]oxy]phenyl)propyl]acetamide | |
0.00178 | - |
isoform ACC1, in 50 mM Tris-acetate, at 37°C, pH not specified in the publication | Homo sapiens | N-[4-(4-[[5-(propan-2-yloxy)pyridin-2-yl]oxy]phenyl)butan-2-yl]acetamide | |
0.0018 | - |
isoform ACC1, in 50 mM Tris-acetate, at 37°C, pH not specified in the publication | Homo sapiens | N-[(2S)-4-(4-[[5-(propan-2-yloxy)pyridin-2-yl]oxy]phenyl)butan-2-yl]acetamide | |
0.0019 | - |
isoform ACC2, in 50 mM Tris-acetate, at 37°C, pH not specified in the publication | Homo sapiens | N-[4-(4-[[6-(propan-2-yloxy)pyridin-3-yl]oxy]phenyl)butan-2-yl]cyclopropanecarboxamide | |
0.0021 | - |
isoform ACC1, in 50 mM Tris-acetate, at 37°C, pH not specified in the publication | Homo sapiens | N-[4-(4-[[5-(benzyloxy)pyridin-2-yl]oxy]phenyl)butan-2-yl]acetamide | |
0.0021 | - |
isoform ACC2, in 50 mM Tris-acetate, at 37°C, pH not specified in the publication | Homo sapiens | N-(3-[5-[3-(2-phenylethoxy)phenyl]-1,3-dioxan-2-yl]propyl)acetamide | |
0.0023 | - |
isoform ACC1, in 50 mM Tris-acetate, at 37°C, pH not specified in the publication | Homo sapiens | N-[(2S)-1-(4-[[6-(propan-2-yloxy)pyridin-3-yl]oxy]phenoxy)propan-2-yl]acetamide | |
0.0026 | - |
isoform ACC1, in 50 mM Tris-acetate, at 37°C, pH not specified in the publication | Homo sapiens | N-[4-(4-[[5-(propan-2-yloxy)pyridin-2-yl]oxy]phenyl)butan-2-yl]acetamide | |
0.0026 | - |
isoform ACC1, in 50 mM Tris-acetate, at 37°C, pH not specified in the publication | Homo sapiens | N-[(2S)-4-(4-[[5-(propan-2-yloxy)pyridin-2-yl]oxy]phenyl)butan-2-yl]acetamide | |
0.00265 | - |
isoform ACC2, in 50 mM Tris-acetate, at 37°C, pH not specified in the publication | Homo sapiens | N-(3-[5-[3-(2-cyclopropylethoxy)phenyl]-1,3-dioxan-2-yl]propyl)acetamide | |
0.0027 | - |
isoform ACC1, in 50 mM Tris-acetate, at 37°C, pH not specified in the publication | Homo sapiens | N-(3-[5-[3-(2-cyclopentylethoxy)phenyl]-1,3-dioxan-2-yl]propyl)acetamide | |
0.0029 | - |
isoform ACC1, in 50 mM Tris-acetate, at 37°C, pH not specified in the publication | Homo sapiens | N-[4-(4-[[5-(cyclopentyloxy)pyridin-2-yl]oxy]phenyl)butan-2-yl]acetamide | |
0.0029 | - |
isoform ACC1, in 50 mM Tris-acetate, at 37°C, pH not specified in the publication | Homo sapiens | methyl [4-(4-[[6-(propan-2-yloxy)pyridin-3-yl]oxy]phenyl)butan-2-yl]carbamate | |
0.0029 | - |
isoform ACC1, in 50 mM Tris-acetate, at 37°C, pH not specified in the publication | Homo sapiens | 1-[4-(4-[[6-(propan-2-yloxy)pyridin-3-yl]oxy]phenyl)butan-2-yl]urea | |
0.003 | - |
isoform ACC1, in 50 mM Tris-acetate, at 37°C, pH not specified in the publication | Homo sapiens | N-[4-(4-[[2-(propan-2-yloxy)pyrimidin-5-yl]oxy]phenyl)butan-2-yl]acetamide | |
0.003 | - |
isoform ACC2, in 50 mM Tris-acetate, at 37°C, pH not specified in the publication | Homo sapiens | 1-[4-(4-[[6-(propan-2-yloxy)pyridin-3-yl]oxy]phenyl)butan-2-yl]urea | |
0.0032 | - |
isoform ACC1, in 50 mM Tris-acetate, at 37°C, pH not specified in the publication | Homo sapiens | N-[4-(4-[[6-(propan-2-yloxy)pyridin-3-yl]oxy]phenyl)butan-2-yl]cyclopropanecarboxamide | |
0.0039 | - |
isoform ACC2, in 50 mM Tris-acetate, at 37°C, pH not specified in the publication | Homo sapiens | methyl [4-(4-[[6-(propan-2-yloxy)pyridin-3-yl]oxy]phenyl)butan-2-yl]carbamate | |
0.00452 | - |
isoform ACC2, in 50 mM Tris-acetate, at 37°C, pH not specified in the publication | Homo sapiens | N-[4-(4-[[5-(propan-2-yloxy)pyridin-2-yl]oxy]phenyl)butan-2-yl]acetamide | |
0.0057 | - |
isoform ACC1, in 50 mM Tris-acetate, at 37°C, pH not specified in the publication | Homo sapiens | N-[4-(4-[[6-(propan-2-yloxy)pyridin-3-yl]oxy]phenyl)butan-2-yl]formamide | |
0.0067 | - |
isoform ACC2, in 50 mM Tris-acetate, at 37°C, pH not specified in the publication | Homo sapiens | N-[4-(4-[[6-(propan-2-yloxy)pyridazin-3-yl]oxy]phenyl)butan-2-yl]acetamide | |
0.00675 | - |
isoform ACC2, in 50 mM Tris-acetate, at 37°C, pH not specified in the publication | Homo sapiens | N-[(2S)-4-(4-[[5-(propan-2-yloxy)pyridin-2-yl]oxy]phenyl)butan-2-yl]acetamide | |
0.0074 | - |
isoform ACC1, in 50 mM Tris-acetate, at 37°C, pH not specified in the publication | Homo sapiens | N-[4-(4-[[2-(propan-2-yloxy)pyrimidin-5-yl]oxy]phenyl)butan-2-yl]acetamide | |
0.0078 | - |
isoform ACC2, in 50 mM Tris-acetate, at 37°C, pH not specified in the publication | Homo sapiens | N-[(2R)-4-(4-[[6-(propan-2-yloxy)pyridin-3-yl]oxy]phenyl)butan-2-yl]acetamide | |
0.0079 | - |
isoform ACC2, in 50 mM Tris-acetate, at 37°C, pH not specified in the publication | Homo sapiens | N-[4-(4-[[5-(cyclopentyloxy)pyridin-2-yl]oxy]phenyl)butan-2-yl]acetamide | |
0.0079 | - |
isoform ACC2, in 50 mM Tris-acetate, at 37°C, pH not specified in the publication | Homo sapiens | N-[4-(4-[[6-(benzyloxy)pyridin-3-yl]oxy]phenyl)butan-2-yl]acetamide | |
0.0099 | - |
isoform ACC1, in 50 mM Tris-acetate, at 37°C, pH not specified in the publication | Homo sapiens | N-[(2R)-4-(4-[[6-(propan-2-yloxy)pyridin-3-yl]oxy]phenyl)butan-2-yl]acetamide | |
0.01 | - |
IC50 above 0.01 mM, isoform ACC1, in 50 mM Tris-acetate, at 37°C, pH not specified in the publication | Homo sapiens | N-[(2S)-4-[2-[4-(propan-2-yloxy)phenoxy]-1,3-thiazol-5-yl]but-3-yn-2-yl]acetamide | |
0.0105 | - |
isoform ACC1, in 50 mM Tris-acetate, at 37°C, pH not specified in the publication | Homo sapiens | N-[(2S)-1-(4-[[6-(propan-2-yloxy)pyridin-3-yl]oxy]phenoxy)propan-2-yl]acetamide | |
0.011 | - |
isoform ACC1, in 50 mM Tris-acetate, at 37°C, pH not specified in the publication | Homo sapiens | N-[4-(4-[[6-(propan-2-yloxy)pyridin-3-yl]oxy]phenyl)butan-2-yl]formamide | |
0.012 | - |
isoform ACC1, in 50 mM Tris-acetate, at 37°C, pH not specified in the publication | Homo sapiens | N-(3-[trans-5-[4-(cyclopentyloxy)phenoxy]-1,3-dioxan-2-yl]propyl)acetamide | |
0.012 | - |
isoform ACC2, in 50 mM Tris-acetate, at 37°C, pH not specified in the publication | Homo sapiens | N-(3-[trans-5-[4-(cyclopentyloxy)phenoxy]-1,3-dioxan-2-yl]propyl)acetamide | |
0.0127 | - |
isoform ACC1, in 50 mM Tris-acetate, at 37°C, pH not specified in the publication | Homo sapiens | N-[4-(4-[[6-(propan-2-yloxy)pyridazin-3-yl]oxy]phenyl)butan-2-yl]acetamide | |
0.013 | - |
isoform ACC1, in 50 mM Tris-acetate, at 37°C, pH not specified in the publication | Homo sapiens | N-(3-[trans-5-[4-(cyclopentyloxy)phenoxy]-1,3-dioxan-2-yl]propyl)acetamide | |
0.014 | - |
isoform ACC1, in 50 mM Tris-acetate, at 37°C, pH not specified in the publication | Homo sapiens | N-[3-(trans-5-[[5-(benzyloxy)pyridin-2-yl]oxy]-1,3-dioxan-2-yl)propyl]acetamide | |
0.017 | - |
isoform ACC2, in 50 mM Tris-acetate, at 37°C, pH not specified in the publication | Homo sapiens | N-(3-[5-[3-(2-cyclopentylethoxy)phenyl]-1,3-dioxan-2-yl]propyl)acetamide | |
0.017 | - |
isoform ACC2, in 50 mM Tris-acetate, at 37°C, pH not specified in the publication | Homo sapiens | N-[4-(4-[[6-(propan-2-yloxy)pyridin-3-yl]oxy]phenyl)butan-2-yl]formamide | |
0.02 | - |
isoform ACC2, in 50 mM Tris-acetate, at 37°C, pH not specified in the publication | Homo sapiens | N-[4-(4-[[2-(propan-2-yloxy)pyrimidin-5-yl]oxy]phenyl)butan-2-yl]acetamide | |
0.025 | - |
isoform ACC1, in 50 mM Tris-acetate, at 37°C, pH not specified in the publication | Homo sapiens | N-(3-[5-[3-(2-cyclopentylethoxy)phenyl]-1,3-dioxan-2-yl]propyl)acetamide | |
0.03 | - |
IC50 above 0.03 mM, isoform ACC1, in 50 mM Tris-acetate, at 37°C, pH not specified in the publication | Homo sapiens | N-[3-(trans-5-[[5-(benzyloxy)pyridin-2-yl]oxy]-1,3-dioxan-2-yl)propyl]acetamide | |
0.03 | - |
IC50 above 0.03 mM, isoform ACC1, in 50 mM Tris-acetate, at 37°C, pH not specified in the publication | Homo sapiens | N-[(2R)-4-(4-[[6-(propan-2-yloxy)pyridin-3-yl]oxy]phenyl)butan-2-yl]acetamide | |
0.03 | - |
IC50 above 0.03 mM, isoform ACC1, in 50 mM Tris-acetate, at 37°C, pH not specified in the publication | Homo sapiens | N-[4-(4-[[6-(propan-2-yloxy)pyridazin-3-yl]oxy]phenyl)butan-2-yl]acetamide | |
0.03 | - |
IC50 above 0.03 mM, isoform ACC1, in 50 mM Tris-acetate, at 37°C, pH not specified in the publication | Homo sapiens | N-(3-[5-[6-(cyclopentyloxy)naphthalen-1-yl]-1,3-dioxan-2-yl]propyl)acetamide | |
0.03 | - |
IC50 above 0.03 mM, isoform ACC1, in 50 mM Tris-acetate, at 37°C, pH not specified in the publication | Homo sapiens | N-(3-[5-[3-(2-cyclopropylethoxy)phenyl]-1,3-dioxan-2-yl]propyl)acetamide | |
0.03 | - |
IC50 above 0.03 mM, isoform ACC1, in 50 mM Tris-acetate, at 37°C, pH not specified in the publication | Homo sapiens | N-(3-[5-[3-(2-phenylethoxy)phenyl]-1,3-dioxan-2-yl]propyl)acetamide | |
0.03 | - |
IC50 above 0.03 mM, isoform ACC1, in 50 mM Tris-acetate, at 37°C, pH not specified in the publication | Homo sapiens | N-(3-[5-[3-(cyclobutylmethoxy)phenyl]-1,3-dioxan-2-yl]propyl)acetamide | |
0.03 | - |
IC50 above 0.03 mM, isoform ACC1, in 50 mM Tris-acetate, at 37°C, pH not specified in the publication | Homo sapiens | N-(3-[trans-5-[4-(benzyloxy)phenoxy]-1,3-dioxan-2-yl]propyl)acetamide | |
0.03 | - |
IC50 above 0.03 mM, isoform ACC1, in 50 mM Tris-acetate, at 37°C, pH not specified in the publication | Homo sapiens | N-[3-(4-[[5-(cyclopentyloxy)pyridin-2-yl]oxy]phenyl)propyl]acetamide | |
0.03 | - |
IC50 above 0.03 mM, isoform ACC1, in 50 mM Tris-acetate, at 37°C, pH not specified in the publication | Homo sapiens | N-[4-(4-[[5-(propan-2-yloxy)pyrazin-2-yl]oxy]phenyl)butan-2-yl]acetamide | |
0.03 | - |
IC50 above 0.03 mM, isoform ACC2, in 50 mM Tris-acetate, at 37°C, pH not specified in the publication | Homo sapiens | N-[3-(trans-5-[[5-(benzyloxy)pyridin-2-yl]oxy]-1,3-dioxan-2-yl)propyl]acetamide | |
0.03 | - |
IC50 above 0.03 mM, isoform ACC2, in 50 mM Tris-acetate, at 37°C, pH not specified in the publication | Homo sapiens | N-[4-(4-[[5-(benzyloxy)pyridin-2-yl]oxy]phenyl)butan-2-yl]acetamide | |
0.03 | - |
IC50 above 0.03 mM, isoform ACC2, in 50 mM Tris-acetate, at 37°C, pH not specified in the publication | Homo sapiens | N-[(2S)-4-(4-[[5-(benzyloxy)pyridin-2-yl]oxy]phenyl)butan-2-yl]acetamide | |
0.03 | - |
IC50 above 0.03 mM, isoform ACC2, in 50 mM Tris-acetate, at 37°C, pH not specified in the publication | Homo sapiens | N-[(2R)-4-(4-[[6-(propan-2-yloxy)pyridin-3-yl]oxy]phenyl)butan-2-yl]acetamide | |
0.03 | - |
IC50 above 0.03 mM, isoform ACC2, in 50 mM Tris-acetate, at 37°C, pH not specified in the publication | Homo sapiens | N-[4-(4-[[6-(propan-2-yloxy)pyridazin-3-yl]oxy]phenyl)butan-2-yl]acetamide | |
0.03 | - |
IC50 above 0.03 mM, isoform ACC2, in 50 mM Tris-acetate, at 37°C, pH not specified in the publication | Homo sapiens | N-(3-[5-[6-(cyclopentyloxy)naphthalen-1-yl]-1,3-dioxan-2-yl]propyl)acetamide | |
0.03 | - |
IC50 above 0.03 mM, isoform ACC2, in 50 mM Tris-acetate, at 37°C, pH not specified in the publication | Homo sapiens | N-(3-[5-[3-(2-cyclopropylethoxy)phenyl]-1,3-dioxan-2-yl]propyl)acetamide | |
0.03 | - |
IC50 above 0.03 mM, isoform ACC2, in 50 mM Tris-acetate, at 37°C, pH not specified in the publication | Homo sapiens | N-(3-[5-[3-(2-phenylethoxy)phenyl]-1,3-dioxan-2-yl]propyl)acetamide | |
0.03 | - |
IC50 above 0.03 mM, isoform ACC2, in 50 mM Tris-acetate, at 37°C, pH not specified in the publication | Homo sapiens | N-(3-[5-[3-(cyclobutylmethoxy)phenyl]-1,3-dioxan-2-yl]propyl)acetamide | |
0.03 | - |
IC50 above 0.03 mM, isoform ACC2, in 50 mM Tris-acetate, at 37°C, pH not specified in the publication | Homo sapiens | N-(3-[trans-5-[4-(benzyloxy)phenoxy]-1,3-dioxan-2-yl]propyl)acetamide | |
0.03 | - |
IC50 above 0.03 mM, isoform ACC2, in 50 mM Tris-acetate, at 37°C, pH not specified in the publication | Homo sapiens | N-[3-(4-[[5-(cyclopentyloxy)pyridin-2-yl]oxy]phenyl)propyl]acetamide | |
0.03 | - |
IC50 above 0.03 mM, isoform ACC2, in 50 mM Tris-acetate, at 37°C, pH not specified in the publication | Homo sapiens | N-[4-(4-[[5-(propan-2-yloxy)pyrazin-2-yl]oxy]phenyl)butan-2-yl]acetamide | |
0.03 | - |
IC50 above 0.03 mM, isoform ACC2, in 50 mM Tris-acetate, at 37°C, pH not specified in the publication | Homo sapiens | N-(3-[cis-5-[4-(benzyloxy)phenoxy]-1,3-dioxan-2-yl]propyl)acetamide | |
0.03 | - |
IC50 above 0.03 mM, isoform ACC2, in 50 mM Tris-acetate, at 37°C, pH not specified in the publication | Homo sapiens | N-[(2R)-4-(4-[[5-(benzyloxy)pyridin-2-yl]oxy]phenyl)butan-2-yl]acetamide |